As a part of our continued commitment to excellence and improving the health of the people and communities we serve, Boone Hospital Center is accredited as a Comprehensive Community Cancer program through the Commission on Cancer.
Study of Referral for Potential Neoadjuvant Therapy for Her-2 Positive Breast Cancer
Patients with her-2 positive breast cancer are potential candidates for “neoadjuvant” chemotherapy, or chemotherapy prior to breast surgery... This study thus looked at new breast cancers diagnosed in 2013-14 which were her-2 positive and fit the criteria for possible neoadjuvant therapy to ascertain if they were offered such therapy.
Read the study summary (PDF file)
Breast Axillary Ultrasound Study Findings
In April 2014, BHC completed a Quality Improvement project regarding breast axillary ultrasound study findings.
To improve preoperative diagnosis of lymph node mets, we should consider doing axillary US on any outside case that has not been adequately imaged in addition to stereotactic biopsy cases in which invasive cancer is diagnosed. Education of the breast imaging specialists and technologists involved in breast imaging will also be performed to aide in improving our diagnostic capabilities.
Read the study report (PDF file)
Stage III NSCLC Lung Study for the Assessment of Evaluation and Treatment Planning Conclusion
We examined the outcome of 114 patients with Stage III non-small cell lung cancer from the BHC Cancer Registry. The choice of consolidation chemotherapy was up to the physician and patient. In general, those patients who received consolidation chemotherapy had a good enough performance status that allowed for this treatment. The results were interesting, showing a 20% improvement in overall 1 year survival, but the 5-year survival was the nearly the same, showing an insignificant difference of 21 vs 25.6% overall survival.
Read the study conclusion (PDF file)